Author:
Ferrer-Mallol Elisa,Matthews Clare,Stoodley Madeline,Gaeta Alessandra,George Elinor,Reuben Emily,Johnson Alex,Davies Elin Haf
Abstract
Digital health technologies are transforming the way health outcomes are captured and measured. Digital biomarkers may provide more objective measurements than traditional approaches as they encompass continuous and longitudinal data collection and use of automated analysis for data interpretation. In addition, the use of digital health technology allows for home-based disease assessments, which in addition to reducing patient burden from on-site hospital visits, provides a more holistic picture of how the patient feels and functions in the real world. Tools that can robustly capture drug efficacy based on disease-specific outcomes that are meaningful to patients, are going to be key to the successful development of new treatments. This is particularly important for people living with rare and chronic complex conditions, where therapeutic options are limited and need to be developed using a patient-focused approach to achieve the biggest impact. Working in partnership with patient Organisation Duchenne UK, we co-developed a video-based approach, delivered through a new mobile health platform (DMD Home), to assess motor function in patients with Duchenne muscular dystrophy (DMD), a genetic, rare, muscular disease characterized by the progressive loss of muscle function and strength. Motor function tasks were selected to reflect the “transfer stage” of the disease, when patients are no longer able to walk independently but can stand and weight-bear to transfer. This stage is important for patients and families as it represents a significant milestone in the progression of DMD but it is not routinely captured and/or scored by standard DMD clinical and physiotherapy assessments. A total of 62 videos were submitted by eight out of eleven participants who onboarded the app and were analysed with pose estimation software (OpenPose) that led to the extraction of objective, quantitative measures, including time, pattern of movement trajectory, and smoothness and symmetry of movement. Computer vision analysis of video tasks to identify voluntary or compensatory movements within the transfer stage merits further investigation. Longitudinal studies to validate DMD home as a new methodology to predict progression to the non-ambulant stage will be pursued.
Subject
Pharmacology (medical),Pharmacology
Reference35 articles.
1. Feasibility and reliability of functional mobility measures in children with cri du Chat (5P−) syndrome;Abbruzzese;Pediatr. Phys. Ther.,2020
2. Traditional and digital biomarkers: Two worlds apart?;Babrak;Digit. Biomark.,2019
3. Project HERCULES: The challenges of estimating multi-state model transitions in rare diseases: creating a natural history model for Duchenne muscular dystrophy;Broomfield,2020
4. OpenPose: Realtime multi-person 2D pose estimation using Part Affinity fields;Cao;IEEE Trans. Pattern Anal. Mach. Intell.,2021
5. Reliability and construct validity of the Duchenne video assessment;Contesse;Muscle Nerve,2021
Cited by
5 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献